- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
SNMMI Meeting: New Cardiac PET Study Shows That Severe Obstructive Sleep Apnea Doubles the Risk of Impaired Myocardial Blood Flow
In what may be the first study to examine clinical and polysomnographic aspects of obstructive sleep apnea (OSA) and coronary microvascular disease (CMD), researchers said the frequency of OSA may be a significant factor in the development of heart disease and related complications.
People with severe obstructive sleep apnea (OSA) have more than double the risk of abnormal myocardial blood flow reserve (MFR) in comparison to those with mild or no OSA, according to new cardiac positron emission tomography (PET) research presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2022 Annual Meeting.
In a study of 346 patients who had overnight polysomnographic testing and cardiac PET imaging, researchers from the Yale University School of Medicine examined OSA features with the apnea-hypopnea index (AHI) and defined abnormal MFR with a ratio of stress to resting myocardial blood flow (MBF).
The researchers found that worsening AHI led to an increased frequency of abnormal MFR. Specifically, patients with severe OSA were more than twice as likely to have abnormal MFR in comparison to patients with mild or no OSA, according to univariate and multivariate analyses of the study findings.
“Interestingly, the significant relationship between OSA severity and myocardial blood flow reserve persisted among those with normal heart PET perfusion scans and no prior history of coronary artery disease,” said Ehimen Aneni, MD, MPH, an instructor at the Yale University School of Medicine in New Haven, Connecticut. “The findings of this study may begin to explain why people with obstructive sleep apnea develop heart disease, including heart failure.”
Given the association between abnormal MFR and severe airway obstruction in people with OSA, the authors called for future studies to assess the impact of MFR in determining the risk stratification and prognosis of patients with OSA.
“The findings also suggest that the frequency of obstruction plays a major role in the pathogenesis of coronary microvascular disease (CMD) in OSA and may be a better measure of CMD likelihood than hypoxia or sleepiness symptoms alone,” noted Aneni and colleagues.
The researchers added there was no association between abnormal MFR and body mass index (BMI), hypertension, hyperlipidemia, race, or gender.
Study Examines Prognostic Value of 68Ga-PSMA-11 PET/CT for Patients at High Risk of PCa
June 21st 2024Initial detection of metastatic prostate cancer via 68Ga-PSMA-11 PET/CT was significantly associated with PSA values > 20 ng/ml, ISUP grade > 3 and MRI T-stage > 3, according to research presented recently at the SNMMI conference.
SNMMI: Can Ultra-Low Dose PET Supplant the Need for CT Attenuation Correction?
June 11th 2024Ultra-low dosing with long axial field-of-view positron emission tomography (PET) scanners facilitates qualitative PET imaging at a more than 50 percent reduction of conventional radiation dosing with PET, according to new research presented at the SNMMI 2024 conference.
SNMMI: AI May Enhance Detection and Risk Assessment for Multiple Cancers on Whole-Body PET/CT Scans
June 10th 2024Deep transfer learning may elevate the capability of whole-body PET/CT scans to diagnose multiple cancers, ranging from breast cancer and lung cancer to melanoma and prostate cancer, according to new research presented at the SNMMI conference.
